Olmewon 20 Tablet
Images are for reference. Actual packaging may vary.
Olmesartan Medoxomil (20mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Medical applications
Olmewon 20 Tablet contains Olmesartan Medoxomil 20 mg, an angiotensin II receptor antagonist used primarily for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Olmesartan Medoxomil effectively reduces vasoconstriction and aldosterone secretion, leading to decreased peripheral vascular resistance and lowered blood pressure.
Olmewon 20 is indicated for the treatment of essential hypertension in adults and can be used alone or in combination with other antihypertensive agents to achieve optimal blood pressure control. The medication is generally well tolerated, with common adverse effects including dizziness, headache, and fatigue. It is contraindicated in patients with hypersensitivity to Olmesartan or any of its components and should be used cautiously in individuals with renal impairment or volume depletion.
Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Olmewon 20 should not be used during pregnancy due to the risk of fetal toxicity. Patients are advised to adhere to prescribed dosages and consult healthcare providers before initiating or discontinuing treatment. This medication contributes significantly to cardiovascular risk reduction by controlling hypertension and preventing complications such as stroke, myocardial infarction, and renal damage.
Synthetic imidazole derivative
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Olmewon 20 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Olmewon 20 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Olmewon 20 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Olmewon 20 Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment. Use of Olmewon 20 Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Olmewon 20 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Olmewon 20 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Olmewon 20 Tablet may be needed. Please consult your doctor. No dose adjustment is recommended in patients with mild liver disease.
Regular Checkup
0 reviews for Olmewon 20 Tablet






